Document is current
Any future updates will be listed below
-
Authors
Okamura, Akihiko
Watanabe, Masayuki
Okui, Jun
Matsuda, Satoru
Takemura, Ryo
Kawakubo, Hirofumi
Takeuchi, Hiroya
Muto, Manabu
Kakeji, Yoshihiro
Kitagawa, Yuko
Doki, Yuichiro
- License Information
-
More Information
Article History
First Online: 21 June 2023
Disclosure
: Yuko Kitagawa: relevant financial activities outside the submitted work for Chugai Pharmaceutical Co., Ltd; Taiho Pharmaceutical Co., Ltd; Yakult Honsha Co. Ltd; Asahi Kasei Pharma Corporation; Otsuka Pharmaceutical Co., Ltd; Takeda Pharmaceutical Co., Ltd; Ono Pharmaceutical Co., Ltd; Tsumura & Co.; Kyouwa Hakkou Kirin Co., Ltd; EA Pharma Co., Ltd; Medicon Inc.; Kaken Pharmaceutical Co. Ltd; Eisai Co., Ltd; Otsuka Pharmaceutical Factory Inc.; Teijin Pharma Ltd; Nihon Pharmaceutical Co., Ltd; Nippon Covidien Inc.; Shionogi & Co., Ltd; Ethicon, Inc.; Olympus Corporation; Bristol-Myers Squibb K.K.; AstraZeneca K.K.; MSD K.K.; Smith & Nephew KK; Aska Pharmaceutical Co., Ltd; and Miyarisan Pharmaceutical Co. Ltd. Akihiko Okamura, Masayuki Watanabe, Jun Okui, Satoru Matsuda, Ryo Takemura, Hirofumi Kawakubo, Hiroya Takeuchi, Manabu Muto, Yoshihiro Kakeji, and Yuichiro Doki have no relevant conflicts of interest to declare.
